Cognito Therapeutics Group, INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersCambridge, MA
SAM.gov UEIH7Z3B8BU47J4
Cognito Therapeutics develops Spectris, an investigational non-invasive therapy platform that delivers audiovisual stimulation to evoke specific brain wave activity in patients with Alzheimer's disease and other neurodegenerative diseases. The therapy is designed to preserve brain structure, cognition, and function, and is administered at home for one hour daily using a headset. The company has conducted a feasibility study called OVERTURE that showed slowing of disease progression among treated patients.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Cognito Therapeutics Group, INC. | Cambridge | MA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.